Literature DB >> 7204361

Toxic psychosis following use of quinacrine.

J P Lindenmayer, P Vargas.   

Abstract

Toxic psychosis due to quinacrine treatment represents an infrequent, but serious psychiatric complication. Psychiatrists should be familiar with this side effect as quinacrine continues to be used as an antimalarial, as an antihelmintic and as an antineoplastic agent. A case of a young male is presented who developed an acute toxic psychosis which necessitated psychiatric hospitalization. The case is discussed in light of previously published clinical reports and experimental studies. It appears that quinacrine acts as a cortical stimulant, but the exact mechanism of its action on the CNS is not clear at this point.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204361

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  Quinacrine induced mood disturbance--the unmasking of bipolar affective disorder.

Authors:  John Lally; Fintan Byrne; Elizabeth Walsh
Journal:  BMJ Case Rep       Date:  2012-06-21

Review 2.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

Review 3.  Clinical features and management of poisoning due to antimalarial drugs.

Authors:  A Jaeger; P Sauder; J Kopferschmitt; F Flesch
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

4.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712

5.  Inward rectifier potassium (Kir) current in dopaminergic periglomerular neurons of the mouse olfactory bulb.

Authors:  Mirta Borin; Alex Fogli Iseppe; Angela Pignatelli; Ottorino Belluzzi
Journal:  Front Cell Neurosci       Date:  2014-08-08       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.